Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic

被引：1
|
作者：
Kow, Chia Siang [1 ]
Hasan, Syed Shahzad [2 ,3 ]
机构：
[1] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia
[2] Univ Huddersfield, Dept Pharm, Huddersfield, W Yorkshire, England
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2021年 / 19卷 / 01期
关键词：
ANTIHYPERTENSIVE DRUGS; OUTCOME INCIDENCE; RISK; ANGIOEDEMA;
D O I：
10.1080/14779072.2021.1842050
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [1] Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
    Omboni, Stefano
    Volpe, Massimo
    ADVANCES IN THERAPY, 2019, 36 (02) : 278 - 297
  • [2] Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
    Verdecchia, Paolo
    Angeli, Fabio
    Mazzotta, Giovanni
    Ambrosio, Giuseppe
    Reboldi, Gianpaolo
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (06) : 742 - 746
  • [3] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan, Norman M.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (08) : 582 - 583
  • [4] Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
    Khalili, Azadeh
    Karim, Hosein
    Bayat, Gholamreza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (04) : 312 - 316
  • [5] Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study
    Hakeam, Hakeam A.
    Alsemari, Muhannad
    Al Duhailib, Zainab
    Ghonem, Leen
    Alharbi, Saad A.
    Almutairy, Eid
    Bin Sheraim, Nader M.
    Alsalhi, Meshal
    Alhijji, Ali
    AlQahtani, Sara
    Khalid, Mohammed
    Barry, Mazin
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (03) : 244 - 252
  • [6] Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease
    Tse, Gary
    Zhou, Jiandong
    Lee, Sharen
    Wong, Wing Tak
    Li, Xintao
    Liu, Tong
    Cao, Zhidong
    Zeng, Daniel Dajun
    Wai, Abraham K. C.
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1717 - 1724
  • [7] Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis
    Hasegawa, Daisuke
    Lee, Young Im
    Prasitlumkum, Narut
    Chopra, Lakshay
    Nishida, Kazuki
    Smith, Robert L.
    Sato, Ryota
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 69 - 77
  • [8] Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on the Inflammatory Response and Viral Clearance in COVID-19 Patients
    Huang, Linna
    Chen, Ziying
    Ni, Lan
    Chen, Lei
    Zhou, Changzhi
    Gao, Chang
    Wu, Xiaojing
    Hua, Lin
    Huang, Xu
    Cui, Xiaoyang
    Tian, Ye
    Zhang, Zeyu
    Zhan, Qingyuan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [9] Patients with hypertension hospitalized with COVID-19 pneumonia using angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers or other antihypertensives: retrospective analysis of 435 patients
    Baslilar, Seyma
    Saylan, Bengu
    ANNALS OF SAUDI MEDICINE, 2021, 41 (05) : 268 - 273
  • [10] Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Vena, Gino A.
    Cassano, Nicoletta
    Coco, Valeria
    De Simone, Clara
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2013, 35 (03) : 447 - 450
12345